Mohamed Hoesein Firdaus A A, Schmidt Michael, Mets Onno M, Gietema Hester A, Lammers Jan-Willem J, Zanen Pieter, de Koning Harry J, van der Aalst Carlijn, Oudkerk Matthijs, Vliegenthart Rozemarijn, Isgum Ivana, Prokop Mathias, van Ginneken Bram, van Rikxoort Eva M, de Jong Pim A
Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Fraunhofer MEVIS, Institute for Medical Image Computing, Bremen, Germany.
Respir Med. 2014 Jan;108(1):136-43. doi: 10.1016/j.rmed.2013.08.014. Epub 2013 Aug 30.
Finding phenotypes within COPD patients may prove imperative for optimizing treatment and prognosis. We hypothesized that it would be possible to discriminate emphysematous, large airway wall thickening and small airways disease dominant phenotypes.
Inspiratory and expiratory CTs were performed in 1140 male smokers without or with mild COPD to quantify emphysema, airway wall thickness and air trapping. Spirometry, residual volume to total lung capacity (RV/TLC) and diffusion capacity (Kco) were measured. Dominant phenotype (emphysema, airway wall thickening or air trapping dominant) was defined as one of the respective CT measure in the upper quartile, with the other measures not in the upper quartile.
573 subjects had any of the three CT measures in the upper quartile. Of these, 367 (64%) were in a single dominant group and 206 (36%) were in a mixed group. Airway wall thickening dominance was associated with younger age (p < 0.001), higher body mass index (p < 0.001), more wheezing (p < 0.05) and lower FEV1 %predicted (p < 0.001). Emphysema dominant subjects had lower FEV1/FVC (p < 0.05) and Kco %predicted (p < 0.05). There was no significant difference in respiratory related hospitalizations (p = 0.09).
CT measures can discriminate three different CT dominant groups of disease in male smokers without or with mild COPD.
ISRCTN63545820, registered at www.trialregister.nl.
在慢性阻塞性肺疾病(COPD)患者中寻找表型对于优化治疗和预后可能至关重要。我们假设能够区分以肺气肿、大气道壁增厚和小气道疾病为主的表型。
对1140名无COPD或患有轻度COPD的男性吸烟者进行吸气和呼气CT检查,以量化肺气肿、气道壁厚度和气体潴留情况。测量肺功能、残气量与肺总量(RV/TLC)之比以及弥散能力(Kco)。主要表型(肺气肿、气道壁增厚或气体潴留为主)定义为相应CT测量值处于上四分位数,而其他测量值不在上四分位数。
573名受试者的三项CT测量值中有任何一项处于上四分位数。其中,367名(64%)属于单一主要组,206名(36%)属于混合组。气道壁增厚为主与年龄较轻(p<0.001)、体重指数较高(p<0.001)、喘息较多(p<0.05)以及预测的第一秒用力呼气容积(FEV1)百分比降低(p<0.001)相关。以肺气肿为主的受试者FEV1/用力肺活量(FVC)较低(p<0.05),预测的Kco百分比也较低(p<0.05)。呼吸相关住院率无显著差异(p=0.09)。
CT测量能够区分无COPD或患有轻度COPD的男性吸烟者中三种不同的CT主要疾病组。
ISRCTN63545820,在www.trialregister.nl注册。